After years working in labs studying the cell cycle and the genetics of human disease, Gennaro D'Urso founded Genetic Networks, a for-profit company focused on drug discovery. As a teenager, D’Urso lost vision in both of his eyes due to a genetic eye condition. He later received a corneal transplant, which allowed him to regain 20/20 vision in one of his eyes. This event led him to switch majors from business to science, and he eventually received his Ph.D. in Molecular Genetics.
During his years of research, he focused on understanding how genes and proteins work together and how they can be identified and cataloged. While many drug companies look at gene targets that have the potential to be effective, he believes that the way drugs are currently tested is often unsustainable and inefficient due to the failure rates and associated research costs.
Gennaro D'Urso is presenting at Investing in Digital Enterprises and Assets Summit (I.D.E.A.S.), CoinDesk's newest event revealing the...
Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.
INN caught up with cryptocurrency investment expert Dan Hoover to review the current landscape and where the market may be heading. The cryptocurrency investment marketplace has gone through severa...